Clinical Study
Melatonin Supplementation in Patients with Complete Tetraplegia and Poor Sleep
Table 1
Individual characteristics of each participant.
| | Participant code | Sex | Age (yrs) | BMI (kg/m2) | Injury level and AIS score | Years since SCI | Medications | Treatment |
| | 1 | M | 46 | 32.9 | C5A | 23.3 | Baclofen, Temazepam | CPAP | | 2 | M | 68 | 27.7 | C4A | 23.9 | Baclofen | CPAP | | 3 | F | 28 | 20.3 | C5A | 4.10 | Baclofen, Diazepam | — | | 4 | M | 42 | 20.8 | C6A | 17.10 | Baclofen, Diazepam | Oral Splint | | 5 | M | 26 | 18.5 | C6A | 10.10 | Baclofen | — |
| | Positive control | | | | | | | |
| | 1 | M | 43 | 24.8 | — | — | — | — | | 2 | F | 31 | 20.7 | — | — | — | — |
|
|
BMI: Body Mass Index, AIS: American Spinal Injury Association Impairment Scale, SCI: Spinal Cord Injury, CPAP: Continuous Positive Airway Pressure.
|
